These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1405280)

  • 21. Is there something special about ischemic heart disease in patients undergoing dialysis?
    Herzog CA
    Am Heart J; 2004 Jun; 147(6):942-4. PubMed ID: 15199336
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prioritization problems in the prevention of ischemic heart disease].
    Hansen JF; Videbaek J
    Ugeskr Laeger; 1999 Feb; 161(7):973-4. PubMed ID: 10051814
    [No Abstract]   [Full Text] [Related]  

  • 23. [The selection of subjects for priority examination for the detection of ischemic heart disease].
    Kochnova VA; Mordashova NIu; Burtsev VI
    Klin Med (Mosk); 1995; 73(1):14-6. PubMed ID: 7791293
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyperlipoproteinemic states and ischemic heart disease.
    Prusinski L; Eisold JF
    Dent Clin North Am; 1996 Jul; 40(3):563-84. PubMed ID: 8829046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of ischemic heart disease].
    Kalinina AM; Chazova LV
    Kardiologiia; 1992 Sep; 32(9-10):80-8. PubMed ID: 1287320
    [No Abstract]   [Full Text] [Related]  

  • 26. [The significance of variation pulsometry in the diagnosis of ischemic heart disease during mass screening of the population].
    Andreev AN; Varaksin AN; Duman VL; Izmozherova NV; Popov AA; Zhivoderov AA; Gorbich LG
    Klin Med (Mosk); 1997; 75(12):26-9. PubMed ID: 9503807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardiologists opinion on the situation of the secondary prevention of ischemic heart disease in Spain].
    De Velasco JA; Del Campo A; Heras M; Macaya C
    Med Clin (Barc); 2009 Apr; 132(15):599-602. PubMed ID: 19409296
    [No Abstract]   [Full Text] [Related]  

  • 28. [Angiogenin--new important parameter in the assessment of ischaemic heart disease?].
    Siebert J; Reiwer-Gostomska M
    Kardiol Pol; 2006 Aug; 64(8):899-900. PubMed ID: 16981062
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevention of ischemic heart disease--the absolute risk].
    Iversen L
    Ugeskr Laeger; 1999 Feb; 161(5):572. PubMed ID: 9989188
    [No Abstract]   [Full Text] [Related]  

  • 30. [Food and secondary prevention of ischemic heart disease].
    Nordestgaard BG; Jensen GB
    Ugeskr Laeger; 1996 Nov; 158(48):6881. PubMed ID: 8984746
    [No Abstract]   [Full Text] [Related]  

  • 31. [Program for ischemic heart disease prevention].
    Katsumura T; Murase N
    Nihon Rinsho; 2011 Sep; 69 Suppl 7():622-6. PubMed ID: 22519062
    [No Abstract]   [Full Text] [Related]  

  • 32. [Secondary prevention of patients with documented ischemic heart disease].
    Haghfelt TH
    Ugeskr Laeger; 1999 Jun; 161(24):3630. PubMed ID: 10507946
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevention of recurrence of ischemic heart disease: discussion].
    Matsuoka H; Ishimura T; Saito T; Hiromori K; Yanbe Y
    Nihon Naika Gakkai Zasshi; 1997 Feb; 86(2):283-300. PubMed ID: 9139067
    [No Abstract]   [Full Text] [Related]  

  • 34. Canadian Cardiovascular Society 2000 Consensus Conference: Women and Ischemic Heart Disease.
    Can J Cardiol; 2001 Nov; 17 Suppl D():3D-69D. PubMed ID: 11726990
    [No Abstract]   [Full Text] [Related]  

  • 35. [Alcohol as prevention of ischemic heart and cerebral disease?].
    Mikkelsen B
    Ugeskr Laeger; 1999 Oct; 161(41):5696-7. PubMed ID: 10565244
    [No Abstract]   [Full Text] [Related]  

  • 36. [Meta-analysis of therapeutic trials of primary prevention in ischemic cardiopathies by hypocholesteremic treatment].
    Cucherat M; Boissel JP; Collet JP
    Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():105-8. PubMed ID: 1285686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diet and secondary prevention of ischemic heart disease].
    Stender S; Astrup AV; Dyerberg J; Faergeman O; Godtfredsen J; Marckmann P; Viggers L; Lind EM
    Ugeskr Laeger; 1997 Feb; 159(8):1119-21. PubMed ID: 9072862
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cracovian program for secondary prevention of ischemic heart disease. Methods of intervention].
    Kawecka-Jaszcz K; Pajak A; Jankowski P
    Przegl Lek; 2003; 60(3):133-5. PubMed ID: 14575012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of ischemic heart disease. Testing of three different methods for prediction of the risk of developing ischemic heart disease].
    Heebøll-Nielsen NC
    Ugeskr Laeger; 2002 Feb; 164(6):769-74. PubMed ID: 11851184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is a silent heart attack?
    Health After 50 Sci Am Consum Health; 2016 Feb; 27(15):7. PubMed ID: 27062759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.